The page is the record's research on the issuer — no analyst, no rating, no view. # Erasca, Inc. (NASDAQ: ERAS) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Erasca, Inc., listed on NASDAQ under ticker ERAS, with ISIN US29479A1088. The LEI is not on the record: no GLEIF record with the exact legal name in jurisdiction US-DE. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The segment is not on the record. The listing status is listed, not halted. ## The disclosure read The record holds 76 filings in the twelve months from 2025-11-08 to 2026-11-08, across 43 filing days. By type, the record holds 3 AGM/EGM, 9 corporate news, 2 director change, 21 directors' dealings, 5 prospectus, 27 regulatory filing, and 9 results. The median gap between filing days is 4.0 days. The latest filing is dated 2026-10-16 and is of type director change, 23 days before the record date of 2026-11-08. The NASDAQ median cadence gap is 6.0 days across 4,359 issuers, with a median of 52 filings and a median latency of 5.0 days. The 2834 Pharmaceutical Preparations sector median cadence gap is 6.0 days across 526 issuers, with a median of 63.0 filings and a median latency of 4.0 days. ## Auditor The auditor is not on the record: no dei:AuditorName tag on the latest annual report cover, which foreign private issuers and older filings do not carry. The auditor location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations page. The state is none found, with a count of 0. ## Open research No openly published research notes are on the record. The state is none found. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's vintage is sealed, with earliest sealed date 2021-01-04. The live record began 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001761918.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/ERAS (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/ERAS (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/ERAS · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp